Anthrax: an overview
by A. Akula, J.P. Gomedhikam, M.K. Kota, V.B. Bodhanapu, M. Kalagara, B.P. Kota
International Journal of Risk Assessment and Management (IJRAM), Vol. 5, No. 1, 2005

Abstract: Anthrax is a zoonotic disease that occurs in domesticated and wild animals. Humans become infected by contact with infected animals or contaminated products, but there are no cases of human-to-human transmission. Under natural circumstances, infection occurs by the cutaneous route and extremely rarely, by the inhalational or gastrointestinal routes. Cutaneous anthrax, the most common form is usually curable. A small percentage of cutaneous infections become systemic, and these can be fatal. An aerosol exposure to spores causes inhalational anthrax. This form of disease begins with non-specific symptoms followed in two to three days by the sudden onset of respiratory distress with dyspnea, cyanosis, and stidor. It is rapidly fatal. Treatment consists of massive doses of antibiotics and supportive care. Post exposure antibiotic prophylaxis is effective in experimental animals and should be instituted as soon as possible after exposure. A licensed nonliving vaccine is available for human use.

Online publication date: Mon, 28-Mar-2005

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Risk Assessment and Management (IJRAM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com